Law360, New York (July 14, 2005, 12:00 AM EDT) -- Less than a week after his own ministry said it had struck a deal with Abbott Laboratories to avoid a compulsory license on the AIDS drug Kaletra, Brazil's new health minister denied the existence of an agreement under which his country would refrain from breaking the patent on the drug.
In an interview published Thursday in the newspaper Correio Braziliense, Jose Saraiva Felipe said that, when he took office, he “saw that no deal had been sanctioned.”
“There was no document signed by the government. I...
Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.